RN7SL615P

Across TCGA pan-cancer cohorts, RN7SL615P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL615P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL615P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL615P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC, THCA, and KIRP are the cancer types where RN7SL615P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL615P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.058	.005	5	view →
THCA	All	II,III,IV	−0.083	.007	3	view →
KIRP	Female	All	+0.153	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL615P–KIRC

Open the KIRC breakdown →